1 1460 130 INFLUENCE OF YOGA ON CANCER-RELATED FATIGUE AND ON MEDIATIONAL RELATIONSHIPS BETWEEN CHANGES IN SLEEP AND CANCER-RELATED FATIGUE: A NATIONWIDE, MULTICENTER RANDOMIZED CONTROLLED TRIAL OF YOGA IN CANCER SURVIVORS. BACKGROUND: CANCER-RELATED FATIGUE (CRF) OFTEN CO-OCCURS WITH SLEEP DISTURBANCE AND IS ONE OF THE MOST PERVASIVE TOXICITIES RESULTING FROM CANCER AND ITS TREATMENT. WE AND OTHER INVESTIGATORS HAVE PREVIOUSLY REPORTED THAT YOGA THERAPY CAN IMPROVE SLEEP QUALITY IN CANCER PATIENTS AND SURVIVORS. NO NATIONWIDE MULTICENTER PHASE III RANDOMIZED CONTROLLED TRIAL (RCT) HAS INVESTIGATED WHETHER YOGA THERAPY IMPROVES CRF OR WHETHER IMPROVEMENTS IN SLEEP MEDIATE THE EFFECT OF YOGA ON CRF. WE EXAMINED THE EFFECT OF A STANDARDIZED, 4-WEEK, YOGA THERAPY PROGRAM (YOGA FOR CANCER SURVIVORS [YOCAS]) ON CRF AND WHETHER YOCAS-INDUCED CHANGES IN SLEEP MEDIATED CHANGES IN CRF AMONG SURVIVORS. STUDY DESIGN AND METHODS: FOUR HUNDRED TEN CANCER SURVIVORS WERE RECRUITED TO A NATIONWIDE MULTICENTER PHASE III RCT COMPARING THE EFFECT OF YOCAS TO STANDARD SURVIVORSHIP CARE ON CRF AND EXAMINING THE MEDIATING EFFECTS OF CHANGES IN SLEEP, STEMMING FROM YOGA, ON CHANGES IN CRF. CRF WAS ASSESSED BY THE MULTIDIMENSIONAL FATIGUE SYMPTOM INVENTORY. SLEEP WAS ASSESSED VIA THE PITTSBURGH SLEEP QUALITY INDEX. BETWEEN- AND WITHIN-GROUP INTERVENTION EFFECTS ON CRF WERE ASSESSED BY ANALYSIS OF COVARIANCE AND 2-TAILED T TEST, RESPECTIVELY. PATH ANALYSIS WAS USED TO EVALUATE MEDIATION. RESULTS: YOCAS PARTICIPANTS DEMONSTRATED SIGNIFICANTLY GREATER IMPROVEMENTS IN CRF COMPARED WITH PARTICIPANTS IN STANDARD SURVIVORSHIP CARE AT POST-INTERVENTION ( P < .01). IMPROVEMENTS IN OVERALL SLEEP QUALITY AND REDUCTIONS IN DAYTIME DYSFUNCTION (EG, EXCESSIVE NAPPING) RESULTING FROM YOGA SIGNIFICANTLY MEDIATED THE EFFECT OF YOGA ON CRF (22% AND 37%, RESPECTIVELY, BOTH P < .01). CONCLUSIONS: YOCAS IS EFFECTIVE FOR TREATING CRF AMONG CANCER SURVIVORS; 22% TO 37% OF THE IMPROVEMENTS IN CRF FROM YOGA THERAPY RESULT FROM IMPROVEMENTS IN SLEEP QUALITY AND DAYTIME DYSFUNCTION. ONCOLOGISTS SHOULD CONSIDER PRESCRIBING YOGA TO CANCER SURVIVORS FOR TREATING CRF AND SLEEP DISTURBANCE. 2019 2 2635 39 YOGA FOR TREATING RHEUMATOID ARTHRITIS: A SYSTEMATIC REVIEW AND META-ANALYSIS. PURPOSE: RHEUMATOID ARTHRITIS (RA) IS A PERVASIVE INFLAMMATORY AUTOIMMUNE DISEASE THAT SERIOUSLY IMPAIRS HUMAN HEALTH AND REQUIRES MORE EFFECTIVE NON-PHARMACOLOGIC TREATMENT APPROACHES. THIS STUDY AIMS TO SYSTEMATICALLY REVIEW AND EVALUATE THE EFFICACY OF YOGA FOR PATIENTS WITH RA. METHODS: MEDLINE (THROUGH PUBMED), COCHRANE LIBRARY, EMBASE (THROUGH SCOPUS), AND WEB OF SCIENCE DATABASE WERE SCREENED THROUGH FOR ARTICLES PUBLISHED UNTIL 20 JULY 2020. RANDOMIZED CONTROLLED TRIALS (RCTS) OF YOGA IN PATIENTS WITH RA WERE INCLUDED. OUTCOMES MEASURES WERE PAIN, PHYSICAL FUNCTION, DISEASE ACTIVITY, INFLAMMATORY CYTOKINES, AND GRIP STRENGTH. FOR EACH OUTCOME, STANDARDIZED MEAN DIFFERENCES (SMD) AND 95% CONFIDENCE INTERVALS (CI) WERE CALCULATED. RESULT: TEN TRIALS INCLUDING 840 PATIENTS WITH RA AGED 30-70 YEARS WERE IDENTIFIED, WITH 86% FEMALE PARTICIPANTS. META-ANALYSIS REVEALED A STATISTICALLY SIGNIFICANT OVERALL EFFECT IN FAVOR OF YOGA FOR PHYSICAL FUNCTION (HAQ-DI) (5 RCTS; SMD = -0.32, 95% CI -0.58 TO -0.05, I (2) = 15%, P = 0.02), DISEASE ACTIVITY (DAS-28) (4 RCTS; SMD = -0.38, 95% CI -0.71 TO -0.06, I (2) = 41%, P = 0.02) AND GRIP STRENGTH (2 RCTS; SMD = 1.30, 95% CI 0.47-2.13, I (2) = 63%, P = 0.002). NO EFFECTS WERE FOUND FOR PAIN, TENDER JOINTS, SWOLLEN JOINTS COUNT OR INFLAMMATORY CYTOKINES (I.E., CRP, ESR, IL-6, AND TNF-ALPHA). SUMMARY: THE FINDINGS OF THIS META-ANALYSIS INDICATE THAT YOGA MAY BE BENEFICIAL FOR IMPROVING PHYSICAL FUNCTION, DISEASE ACTIVITY, AND GRIP STRENGTH IN PATIENTS WITH RA. HOWEVER, THE BALANCE OF EVIDENCE SHOWED THAT YOGA HAD NO SIGNIFICANT EFFECT IN IMPROVING PAIN, TENDER JOINTS, SWOLLEN JOINTS COUNT, AND INFLAMMATORY CYTOKINES IN PATIENTS SUFFERING FROM RA. CONSIDERING METHODOLOGICAL LIMITATIONS, SMALL SAMPLE SIZE, AND LOW-QUALITY, WE DRAW A VERY CAUTIOUS CONCLUSION IN THE RESULTS OF THE ESTIMATE OF THE EFFECT. HIGH-QUALITY AND LARGE-SCALE RCTS ARE URGENTLY NEEDED IN THE FUTURE, AND THE REAL RESULT MAY BE SUBSTANTIALLY DIFFERENT. 2020 3 2035 21 TELE-YOGA FOR CHRONIC PAIN: CURRENT STATUS AND FUTURE DIRECTIONS. PAIN IS A PERVASIVE, DEBILITATING DISORDER THAT IS RESISTANT TO LONG-TERM PHARMACOLOGICAL INTERVENTIONS. ALTHOUGH PSYCHOLOGICAL THERAPIES SUCH AS COGNITIVE BEHAVIOR THERAPY DEMONSTRATE MODERATE EFFICACY, MANY INDIVIDUALS CONTINUE TO HAVE ONGOING DIFFICULTIES FOLLOWING TREATMENT. THERE IS A CURRENT TREND TO ESTABLISH COMPLEMENTARY AND INTEGRATIVE HEALTH INTERVENTIONS FOR CHRONIC PAIN, FOR WHICH YOGA HAS BEEN FOUND TO HAVE EXCITING POTENTIAL. NEVERTHELESS, AN IMPORTANT CONSIDERATION WITHIN THE FIELD IS ACCESSIBILITY TO ADEQUATE CARE. TELEHEALTH CAN BE USED TO PROVIDE REAL-TIME INTERACTIVE VIDEO CONFERENCING LEADING TO INCREASED ACCESS TO HEALTH CARE FOR INDIVIDUALS LOCATED REMOTELY OR WHO OTHERWISE HAVE DIFFICULTY ACCESSING SERVICES, PERHAPS THROUGH ISSUES OF MOBILITY OR PROXIMITY OF ADEQUATE SERVICES. THIS ARTICLE ASSESSES THE CURRENT STATUS AND FEASIBILITY OF IMPLEMENTING TELE-YOGA FOR CHRONIC PAIN. METHODOLOGICAL LIMITATIONS AND RECOMMENDATIONS FOR FUTURE RESEARCH ARE DISCUSSED. 2018 4 6 30 "I JUST START CRYING FOR NO REASON": THE EXPERIENCE OF STRESS AND DEPRESSION IN PREGNANT, URBAN, AFRICAN-AMERICAN ADOLESCENTS AND THEIR PERCEPTION OF YOGA AS A MANAGEMENT STRATEGY. PURPOSE: PERINATAL HEALTH DISPARITIES ARE OF PARTICULAR CONCERN WITH PREGNANT, URBAN, AFRICAN-AMERICAN (AA) ADOLESCENTS, WHO HAVE HIGH RATES OF STRESS AND DEPRESSION DURING PREGNANCY, HIGHER RATES OF ADVERSE PREGNANCY AND NEONATAL OUTCOMES, AND MANY BARRIERS TO EFFECTIVE TREATMENT. THE PURPOSE OF THIS STUDY WAS TO EXPLORE PREGNANT, URBAN, AA TEENAGERS' EXPERIENCE OF STRESS AND DEPRESSION AND EXAMINE THEIR PERCEPTIONS OF ADJUNCTIVE NONPHARMACOLOGIC MANAGEMENT STRATEGIES, SUCH AS YOGA. METHODS: THIS COMMUNITY-BASED, QUALITATIVE STUDY USED NONTHERAPEUTIC FOCUS GROUPS TO ALLOW FOR EXPLORATION OF ATTITUDES, CONCERNS, BELIEFS, AND VALUES REGARDING STRESS AND DEPRESSION IN PREGNANCY AND NONPHARMACOLOGIC MANAGEMENT APPROACHES, SUCH AS MIND-BODY THERAPIES AND OTHER PRENATAL ACTIVITIES. FINDINGS: THE SAMPLE CONSISTED OF PREGNANT, AA, LOW-INCOME ADOLESCENTS (N=17) WHO RESIDED IN A LARGE URBAN AREA IN THE UNITED STATES. THE THEMES THAT AROSE IN THE FOCUS GROUP DISCUSSIONS WERE THAT 1) STRESS AND DEPRESSION SYMPTOMS ARE PERVASIVE IN DAILY LIFE, 2) PARTICIPANTS FELT A GENERALIZED SENSE OF ISOLATION, 3) STRESS/DEPRESSION MANAGEMENT TECHNIQUES SHOULD BE GROUP BASED, INTERACTIVE, AND FOCUSED ON THE SPECIFIC NEEDS OF TEENAGERS, AND 4) YOGA IS AN APPEALING STRESS MANAGEMENT TECHNIQUE TO THIS POPULATION. CONCLUSIONS: FINDINGS FROM THIS STUDY SUGGEST THAT PREGNANT, URBAN, ADOLESCENTS ARE HIGHLY STRESSED; THEY INTERPRET DEPRESSION-LIKE SYMPTOMS TO BE SIGNS OF STRESS; THEY DESIRE GROUP-BASED, INTERACTIVE ACTIVITIES; AND THEY ARE INTERESTED IN YOGA CLASSES FOR STRESS/DEPRESSION MANAGEMENT AND RELATIONSHIP BUILDING. IT IS IMPERATIVE THAT HEALTH CARE PROVIDERS AND RESEARCHERS FOCUS ON THESE NEEDS, PARTICULARLY WHEN DESIGNING PREVENTION AND INTERVENTION STRATEGIES. 2015 5 2503 35 YOGA AS TREATMENT FOR INSOMNIA AMONG CANCER PATIENTS AND SURVIVORS: A SYSTEMATIC REVIEW. MANY CANCER PATIENTS AND SURVIVORS, BETWEEN 15 TO 90%, REPORT SOME FORM OF INSOMNIA OR SLEEP QUALITY IMPAIRMENT DURING AND POST-TREATMENT, SUCH AS EXCESSIVE DAYTIME NAPPING, DIFFICULTY FALLING ASLEEP, DIFFICULTY STAYING ASLEEP, AND WAKING UP TOO EARLY. INSOMNIA AND SLEEP QUALITY IMPAIRMENT ARE AMONG THE MOST PREVALENT AND DISTRESSING PROBLEMS REPORTED BY CANCER PATIENTS AND SURVIVORS, AND CAN BE SEVERE ENOUGH TO INCREASE CANCER MORTALITY. DESPITE THE UBIQUITY OF INSOMNIA AND SLEEP QUALITY IMPAIRMENT, THEY ARE UNDER-DIAGNOSED AND UNDER-TREATED IN CANCER PATIENTS AND SURVIVORS. WHEN SLEEP PROBLEMS ARE PRESENT, PROVIDERS AND PATIENTS ARE OFTEN HESITANT TO PRESCRIBE OR TAKE PHARMACEUTICALS FOR SLEEP PROBLEMS DUE TO POLY PHARMACY CONCERNS, AND COGNITIVE BEHAVIORAL THERAPY FOR INSOMNIA CAN BE VERY DIFFICULT AND IMPRACTICAL FOR PATIENTS TO ADHERE TO THROUGHOUT THE CANCER EXPERIENCE. RESEARCH SUGGESTS YOGA IS A WELL-TOLERATED EXERCISE INTERVENTION WITH PROMISING EVIDENCE FOR ITS EFFICACY IN IMPROVING INSOMNIA AND SLEEP QUALITY IMPAIRMENT AMONG SURVIVORS. THIS ARTICLE PROVIDES A SYSTEMATIC REVIEW OF EXISTING CLINICAL RESEARCH ON THE EFFECTIVENESS OF YOGA FOR TREATING INSOMNIA AND SLEEP QUALITY IMPAIRMENT AMONG CANCER PATIENTS AND SURVIVORS. 2013 6 2627 30 YOGA FOR THE MANAGEMENT OF CANCER TREATMENT-RELATED TOXICITIES. PURPOSE OF REVIEW: TO (1) EXPLAIN WHAT YOGA IS, (2) SUMMARIZE PUBLISHED LITERATURE ON THE EFFICACY OF YOGA FOR MANAGING CANCER TREATMENT-RELATED TOXICITIES, (3) PROVIDE CLINICAL RECOMMENDATIONS ON THE USE OF YOGA FOR ONCOLOGY PROFESSIONALS, AND (4) SUGGEST PROMISING AREAS FOR FUTURE RESEARCH. RECENT FINDINGS: BASED ON A TOTAL OF 24 PHASE II AND ONE PHASE III CLINICAL TRIALS, LOW-INTENSITY FORMS OF YOGA, SPECIFICALLY GENTLE HATHA AND RESTORATIVE, ARE FEASIBLE, SAFE, AND EFFECTIVE FOR TREATING SLEEP DISRUPTION, CANCER-RELATED FATIGUE, COGNITIVE IMPAIRMENT, PSYCHOSOCIAL DISTRESS, AND MUSCULOSKELETAL SYMPTOMS IN CANCER PATIENTS RECEIVING CHEMOTHERAPY AND RADIATION AND CANCER SURVIVORS. CLINICIANS SHOULD CONSIDER PRESCRIBING YOGA FOR THEIR PATIENTS SUFFERING WITH THESE TOXICITIES BY REFERRING THEM TO QUALIFIED YOGA PROFESSIONALS. MORE DEFINITIVE PHASE III CLINICAL TRIALS ARE NEEDED TO CONFIRM THESE FINDINGS AND TO INVESTIGATE OTHER TYPES, DOSES, AND DELIVERY MODES OF YOGA FOR TREATING CANCER-RELATED TOXICITIES IN PATIENTS AND SURVIVORS. 2018 7 2382 55 YOCAS(C)(R) YOGA REDUCES SELF-REPORTED MEMORY DIFFICULTY IN CANCER SURVIVORS IN A NATIONWIDE RANDOMIZED CLINICAL TRIAL: INVESTIGATING RELATIONSHIPS BETWEEN MEMORY AND SLEEP. UNLABELLED: BACKGROUND INTERVENTIONS ARE NEEDED TO ALLEVIATE MEMORY DIFFICULTY IN CANCER SURVIVORS. WE PREVIOUSLY SHOWED IN A PHASE III RANDOMIZED CLINICAL TRIAL THAT YOCAS(C)(R) YOGA-A PROGRAM THAT CONSISTS OF BREATHING EXERCISES, POSTURES, AND MEDITATION-SIGNIFICANTLY IMPROVED SLEEP QUALITY IN CANCER SURVIVORS. THIS STUDY ASSESSED THE EFFECTS OF YOCAS(C)(R) ON MEMORY AND IDENTIFIED RELATIONSHIPS BETWEEN MEMORY AND SLEEP. STUDY DESIGN AND METHODS: SURVIVORS WERE RANDOMIZED TO STANDARD CARE (SC) OR SC WITH YOCAS(C)(R) . 328 PARTICIPANTS WHO PROVIDED DATA ON THE MEMORY DIFFICULTY ITEM OF THE MD ANDERSON SYMPTOM INVENTORY ARE INCLUDED. SLEEP QUALITY WAS MEASURED USING THE PITTSBURGH SLEEP QUALITY INDEX. GENERAL LINEAR MODELING (GLM) DETERMINED THE GROUP EFFECT OF YOCAS(C)(R) ON MEMORY DIFFICULTY COMPARED WITH SC. GLM ALSO DETERMINED MODERATION OF BASELINE MEMORY DIFFICULTY ON POSTINTERVENTION SLEEP AND VICE VERSA. PATH MODELING ASSESSED THE MEDIATING EFFECTS OF CHANGES IN MEMORY DIFFICULTY ON YOCAS(C)(R) CHANGES IN SLEEP AND VICE VERSA. RESULTS: YOCAS(C)(R) SIGNIFICANTLY REDUCED MEMORY DIFFICULTY AT POSTINTERVENTION COMPARED WITH SC (MEAN CHANGE: YOGA=-0.60; SC=-0.16; P<.05). BASELINE MEMORY DIFFICULTY DID NOT MODERATE THE EFFECTS OF POSTINTERVENTION SLEEP QUALITY IN YOCAS(C)(R) COMPARED WITH SC. BASELINE SLEEP QUALITY DID MODERATE THE EFFECTS OF POSTINTERVENTION MEMORY DIFFICULTY IN YOCAS(C)(R) COMPARED WITH SC (P<.05). CHANGES IN SLEEP QUALITY WAS A SIGNIFICANT MEDIATOR OF REDUCED MEMORY DIFFICULTY IN YOCAS(C)(R) COMPARED WITH SC (P<.05); HOWEVER, CHANGES IN MEMORY DIFFICULTY DID NOT SIGNIFICANTLY MEDIATE IMPROVED SLEEP QUALITY IN YOCAS(C)(R) COMPARED WITH SC. CONCLUSIONS: IN THIS LARGE NATIONWIDE TRIAL, YOCAS(C)(R) YOGA SIGNIFICANTLY REDUCED PATIENT-REPORTED MEMORY DIFFICULTY IN CANCER SURVIVORS. 2016 8 2631 28 YOGA FOR THE TREATMENT OF INSOMNIA AMONG CANCER PATIENTS: EVIDENCE, MECHANISMS OF ACTION, AND CLINICAL RECOMMENDATIONS. UP TO 90% OF CANCER PATIENTS REPORT SYMPTOMS OF INSOMNIA DURING AND AFTER TREATMENT. SYMPTOMS OF INSOMNIA INCLUDE EXCESSIVE DAYTIME SLEEPINESS, DIFFICULTY FALLING ASLEEP, DIFFICULTY STAYING ASLEEP, AND WAKING UP TOO EARLY. INSOMNIA SYMPTOMS ARE AMONG THE MOST PREVALENT, DISTRESSING AND PERSISTENT CANCER- AND CANCER TREATMENT-RELATED TOXICITIES REPORTED BY PATIENTS, AND CAN BE SEVERE ENOUGH TO INCREASE CANCER MORBIDITY AND MORTALITY. DESPITE THE UBIQUITY OF INSOMNIA SYMPTOMS, THEY ARE UNDER-SCREENED, UNDER-DIAGNOSED, AND UNDER-TREATED IN CANCER PATIENTS. WHEN INSOMNIA SYMPTOMS ARE IDENTIFIED, PROVIDERS ARE HESITANT TO PRESCRIBE, AND PATIENTS ARE HESITANT TO TAKE PHARMACEUTICALS DUE TO POLYPHARMACY CONCERNS. IN ADDITION, SLEEP MEDICATIONS DO NOT CURE INSOMNIA. YOGA IS A WELL-TOLERATED MODE OF EXERCISE WITH PROMISING EVIDENCE FOR ITS EFFICACY IN IMPROVING INSOMNIA SYMPTOMS AMONG CANCER PATIENTS. THIS ARTICLE REVIEWS EXISTING CLINICAL RESEARCH ON THE EFFECTIVENESS OF YOGA FOR TREATING INSOMNIA AMONG CANCER PATIENTS. THE ARTICLE ALSO PROVIDES CLINICAL RECOMMENDATIONS FOR PRESCRIBING YOGA FOR THE TREATMENT OF INSOMNIA IN THIS POPULATION. 2014 9 2129 30 THE EFFECTIVENESS OF YOGA ON CANCER-RELATED FATIGUE: A SYSTEMATIC REVIEW AND META-ANALYSIS. PROBLEM IDENTIFICATION: THE AIM OF THIS ARTICLE IS TO EVALUATE THE EFFECTIVENESS OF YOGA ON CANCER-RELATED FATIGUE (CRF) IN PATIENTS UNDERGOING CHEMOTHERAPY AND/OR RADIATION THERAPY. LITERATURE SEARCH: RELEVANT ENGLISH AND CHINESE ARTICLES WERE RETRIEVED FROM MEDICAL DATABASES AND INCLUDED IN THIS ANALYSIS. STANDARDIZED CRITICAL APPRAISAL INSTRUMENTS FROM THE JOANNA BRIGGS INSTITUTE WERE ADOPTED FOR THE QUALITY ASSESSMENT. DATA EVALUATION: 16 RANDOMIZED CONTROLLED TRIALS MET THE INCLUSION CRITERIA. SYNTHESIS: YOGA INTERVENTIONS HAD A POSITIVE EFFECT IN REDUCING CRF AMONG PATIENTS UNDERGOING CHEMOTHERAPY AND/OR RADIATION THERAPY, BUT THE ADHERENCE TO YOGA WAS LOW. MIXED TYPES OF YOGA, IN ADDITION TO SUPERVISED AND SELF-PRACTICING STRATEGIES, WERE ASSOCIATED WITH INCREASED PATIENT ADHERENCE AND IMPROVED CRF. IMPLICATIONS FOR PRACTICE: YOGA APPEARS TO BE A SAFE AND EFFECTIVE EXERCISE FOR THE MANAGEMENT OF CRF DURING CHEMOTHERAPY AND/OR RADIATION THERAPY; HOWEVER, ADDITIONAL HIGH-QUALITY STUDIES ARE NEEDED TO DEFINE AN OPTIMAL YOGA INTERVENTION STRATEGY. 2021 10 1052 52 EFFECTS OF YOGA ON CANCER-RELATED FATIGUE AND GLOBAL SIDE-EFFECT BURDEN IN OLDER CANCER SURVIVORS. BACKGROUND: SIXTY PERCENT OF CANCER SURVIVORS ARE 65YEARS OF AGE OR OLDER. CANCER AND ITS TREATMENTS LEAD TO CANCER-RELATED FATIGUE AND MANY OTHER SIDE EFFECTS, IN TURN, CREATING SUBSTANTIAL GLOBAL SIDE-EFFECT BURDEN (TOTAL BURDEN FROM ALL SIDE EFFECTS) WHICH, ULTIMATELY, COMPROMISES FUNCTIONAL INDEPENDENCE AND QUALITY OF LIFE. VARIOUS MODES OF EXERCISE, SUCH AS YOGA, REDUCE CANCER-RELATED FATIGUE AND GLOBAL SIDE-EFFECT BURDEN IN YOUNGER CANCER SURVIVORS, BUT NO STUDIES HAVE SPECIFICALLY EXAMINED THE EFFECTS OF YOGA ON OLDER CANCER SURVIVORS. OBJECTIVES: THE PURPOSE OF THIS STUDY WAS TO ASSESS THE EFFECTS OF A 4-WEEK YOGA INTERVENTION (YOGA FOR CANCER SURVIVORS: YOCAS(C)(R)) ON OVERALL CANCER-RELATED FATIGUE, AND DUE TO ITS MULTIDIMENSIONAL NATURE, THE SUBDOMAINS OF CANCER-RELATED FATIGUE (GENERAL, PHYSICAL, EMOTIONAL, AND MENTAL) AND GLOBAL SIDE-EFFECT BURDEN IN OLDER CANCER SURVIVORS. MATERIALS AND METHODS: WE CONDUCTED A SECONDARY ANALYSIS ON DATA FROM A MULTICENTER PHASE III RANDOMIZED CONTROLLED CLINICAL TRIAL WITH 2 ARMS (STANDARD CARE AND STANDARD CARE PLUS A 4-WEEK YOCAS(C)(R) INTERVENTION). THE SAMPLE FOR THIS SECONDARY ANALYSIS WAS 97 OLDER CANCER SURVIVORS (>/=60YEARS OF AGE), BETWEEN 2MONTHS AND 2YEARS POST-TREATMENT, WHO PARTICIPATED IN THE ORIGINAL TRIAL. RESULTS: PARTICIPANTS IN THE YOCAS(C)(R) INTERVENTION ARM REPORTED SIGNIFICANTLY LOWER CANCER-RELATED FATIGUE, PHYSICAL FATIGUE, MENTAL FATIGUE, AND GLOBAL SIDE-EFFECT BURDEN THAN PARTICIPANTS IN THE STANDARD CARE ARM FOLLOWING THE 4-WEEK INTERVENTION PERIOD (P<0.05). CONCLUSIONS: YOCAS(C)(R) IS AN EFFECTIVE STANDARDIZED YOGA INTERVENTION FOR REDUCING CANCER-RELATED FATIGUE, PHYSICAL FATIGUE, MENTAL FATIGUE, AND GLOBAL SIDE-EFFECT BURDEN AMONG OLDER CANCER SURVIVORS. 2015 11 1608 34 META-ANALYSIS OF RANDOMIZED CONTROLLED TRIALS ON YOGA, PSYCHOSOCIAL, AND MINDFULNESS-BASED INTERVENTIONS FOR CANCER-RELATED FATIGUE: WHAT INTERVENTION CHARACTERISTICS ARE RELATED TO HIGHER EFFICACY? CANCER-RELATED FATIGUE (CRF) IS A BURDENSOME SEQUELA OF CANCER TREATMENTS. BESIDES EXERCISE, RECOMMENDED THERAPIES FOR CRF INCLUDE YOGA, PSYCHOSOCIAL, AND MINDFULNESS-BASED INTERVENTIONS. HOWEVER, INTERVENTIONS CONDUCTED VARY WIDELY, AND NOT ALL SHOW A SIGNIFICANT EFFECT. THIS META-ANALYSIS AIMED TO EXPLORE INTERVENTION CHARACTERISTICS RELATED TO GREATER REDUCTIONS IN CRF. WE INCLUDED RANDOMIZED CONTROLLED TRIALS PUBLISHED BEFORE OCTOBER 2021. STANDARDIZED MEAN DIFFERENCES WERE USED TO ASSESS INTERVENTION EFFICACY FOR CRF AND MULTIMODEL INFERENCE TO EXPLORE INTERVENTION CHARACTERISTICS ASSOCIATED WITH HIGHER EFFICACY. FOR THE META-ANALYSIS, WE INCLUDED 70 INTERVENTIONS (24 YOGA INTERVENTIONS, 31 PSYCHOSOCIAL INTERVENTIONS, AND 15 MINDFULNESS-BASED INTERVENTIONS) WITH 6387 PARTICIPANTS. THE RESULTS SHOWED A SIGNIFICANT EFFECT OF YOGA, PSYCHOSOCIAL, AND MINDFULNESS-BASED INTERVENTIONS ON CRF BUT WITH HIGH HETEROGENEITY BETWEEN STUDIES. FOR YOGA AND MINDFULNESS-BASED INTERVENTIONS, NO PARTICULAR INTERVENTION CHARACTERISTIC WAS IDENTIFIED TO BE ADVANTAGEOUS FOR REDUCING CRF. REGARDING PSYCHOSOCIAL INTERVENTIONS, A GROUP SETTING AND WORK ON COGNITION WERE RELATED TO HIGHER INTERVENTION EFFECTS ON CRF. THE RESULTS OF THIS META-ANALYSIS SUGGEST OPTIONS TO MAXIMIZE THE INTERVENTION EFFECTS OF PSYCHOSOCIAL INTERVENTIONS FOR CRF. THE EFFECTS OF YOGA AND MINDFULNESS-BASED INTERVENTIONS FOR CRF APPEAR TO BE INDEPENDENT OF THEIR DESIGN, ALTHOUGH THE LIMITED NUMBER OF STUDIES POINTS TO THE NEED FOR FURTHER RESEARCH. 2022 12 1142 24 EFFICACY, FEASIBILITY, AND ACCEPTABILITY OF PERINATAL YOGA ON WOMEN'S MENTAL HEALTH AND WELL-BEING: A SYSTEMATIC LITERATURE REVIEW. INTRODUCTION: PERINATAL MAJOR DEPRESSIVE DISORDER AFFECTS 20% OF WOMEN, WHILE PERINATAL ANXIETY AFFECTS 10% OF WOMEN. ALTHOUGH PHARMACOLOGICAL TREATMENT HAS SHOWN EFFECTIVENESS, MANY PREGNANT WOMEN ARE CONCERNED ABOUT POTENTIAL ADVERSE EFFECTS ON THE FETUS, MATERNAL-INFANT BONDING, AND CHILD DEVELOPMENT. APPROXIMATELY 38% OF AMERICAN ADULTS USE COMPLEMENTARY AND ALTERNATIVE MEDICINE, INCLUDING YOGA AND OTHER MIND-BODY STRATEGIES. ALTHOUGH COMPLEMENTARY AND ALTERNATIVE MEDICINE HAS BEEN LESS STUDIED IN THE PERINATAL POPULATION, IT POTENTIALLY OFFERS WOMEN AND THEIR PROVIDERS ALTERNATIVES TO TRADITIONAL MEDICATION FOR TREATMENT OF PERINATAL DEPRESSION AND ANXIETY. THUS, THE PURPOSE OF THIS SYSTEMATIC REVIEW WAS TO EXAMINE EXISTING EMPIRICAL LITERATURE ON YOGA AND ITS EFFECTS ON WOMEN'S HEALTH AND WELL-BEING DURING THE PERINATAL PERIOD. METHOD: FOLLOWING PRISMA (PREFERRED REPORTING ITEMS FOR SYSTEMATIC REVIEWS AND META-ANALYSES) GUIDELINES FOR SYSTEMIC LITERATURE REVIEWS, LITERATURE SEARCHES USING RELEVANT SEARCH TERMS WERE PERFORMED IN FOUR MAJOR ELECTRONIC DATABASES: CINAHL, PUBMED, PSYCINFO, AND EMBASE. THIRTEEN PUBLICATIONS MET INCLUSION CRITERIA. RESULTS: RESULTS INDICATED THAT YOGA INTERVENTIONS ARE GENERALLY EFFECTIVE IN REDUCING ANXIETY AND DEPRESSION IN PREGNANT WOMEN. DISCUSSION: THE USE OF YOGA IN THE PERINATAL PERIOD SHOWS PROMISE IN IMPROVING MENTAL HEALTH AND WELL-BEING FOR WOMEN AND INFANTS. THIS REVIEW CAN INFORM FUTURE YOGA INTERVENTION STUDIES AND CLINICAL PRACTICE WITH THE PERINATAL POPULATION. 2016 13 2026 20 TAI CHI AND YOGA AS COMPLEMENTARY THERAPIES IN RHEUMATOLOGIC CONDITIONS. TAI CHI AND YOGA ARE COMPLEMENTARY THERAPIES WHICH HAVE, DURING THE LAST FEW DECADES, EMERGED AS POPULAR TREATMENTS FOR RHEUMATOLOGIC AND MUSCULOSKELETAL DISEASES. THIS REVIEW COVERS THE EVIDENCE OF TAI CHI AND YOGA IN THE MANAGEMENT OF RHEUMATOLOGIC DISEASES, ESPECIALLY OSTEOARTHRITIS OF THE KNEE, HIP AND HAND, AND RHEUMATOID ARTHRITIS. THERE IS EVIDENCE THAT TAI CHI AND YOGA ARE SAFE, AND SOME EVIDENCE THAT THEY HAVE BENEFIT, LEADING TO REDUCTION OF PAIN AND IMPROVEMENT OF PHYSICAL FUNCTION AND QUALITY OF LIFE IN PATIENTS. RECOMMENDATIONS FOR TAI CHI IN KNEE OSTEOARTHRITIS HAVE RECENTLY BEEN ISSUED BY THE AMERICAN COLLEGE OF RHEUMATOLOGY. TO ALLOW BROADER RECOMMENDATIONS FOR THE USE OF TAI CHI AND YOGA IN RHEUMATIC DISEASES, THERE IS A NEED TO COLLECT MORE EVIDENCE RESEARCHED WITH LARGER RANDOMISED CONTROLLED TRIALS. 2012 14 1650 53 MULTICENTER, RANDOMIZED CONTROLLED TRIAL OF YOGA FOR SLEEP QUALITY AMONG CANCER SURVIVORS. PURPOSE: THIRTY PERCENT TO 90% OF CANCER SURVIVORS REPORT IMPAIRED SLEEP QUALITY POST-TREATMENT, WHICH CAN BE SEVERE ENOUGH TO INCREASE MORBIDITY AND MORTALITY. LIFESTYLE INTERVENTIONS, SUCH AS EXERCISE, ARE RECOMMENDED IN CONJUNCTION WITH DRUGS AND COGNITIVE BEHAVIORAL THERAPY FOR THE TREATMENT OF IMPAIRED SLEEP. PRELIMINARY EVIDENCE INDICATES THAT YOGA-A MIND-BODY PRACTICE AND FORM OF EXERCISE-MAY IMPROVE SLEEP AMONG CANCER SURVIVORS. THE PRIMARY AIM OF THIS RANDOMIZED, CONTROLLED CLINICAL TRIAL WAS TO DETERMINE THE EFFICACY OF A STANDARDIZED YOGA INTERVENTION COMPARED WITH STANDARD CARE FOR IMPROVING GLOBAL SLEEP QUALITY (PRIMARY OUTCOME) AMONG POST-TREATMENT CANCER SURVIVORS. PATIENTS AND METHODS: IN ALL, 410 SURVIVORS SUFFERING FROM MODERATE OR GREATER SLEEP DISRUPTION BETWEEN 2 AND 24 MONTHS AFTER SURGERY, CHEMOTHERAPY, AND/OR RADIATION THERAPY WERE RANDOMLY ASSIGNED TO STANDARD CARE OR STANDARD CARE PLUS THE 4-WEEK YOGA INTERVENTION. THE YOGA INTERVENTION USED THE YOGA FOR CANCER SURVIVORS (YOCAS) PROGRAM CONSISTING OF PRANAYAMA (BREATHING EXERCISES), 16 GENTLE HATHA AND RESTORATIVE YOGA ASANAS (POSTURES), AND MEDITATION. PARTICIPANTS ATTENDED TWO 75-MINUTE SESSIONS PER WEEK. SLEEP QUALITY WAS ASSESSED BY USING THE PITTSBURGH SLEEP QUALITY INDEX AND ACTIGRAPHY PRE- AND POSTINTERVENTION. RESULTS: IN ALL, 410 SURVIVORS WERE ACCRUED (96% FEMALE; MEAN AGE, 54 YEARS; 75% HAD BREAST CANCER). YOGA PARTICIPANTS DEMONSTRATED GREATER IMPROVEMENTS IN GLOBAL SLEEP QUALITY AND, SECONDARILY, SUBJECTIVE SLEEP QUALITY, DAYTIME DYSFUNCTION, WAKE AFTER SLEEP ONSET, SLEEP EFFICIENCY, AND MEDICATION USE AT POSTINTERVENTION (ALL P